Navigation Links
New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
Date:1/13/2009

-Growing Body of Data Supports XELOX as Effective Alternative to Standard of Care-

NUTLEY, N.J., Jan. 13 /PRNewswire-FirstCall/ -- Overall survival results from a 14-month follow-up of the international, Phase III NO16966 study confirm that oral Xeloda(R) plus oxaliplatin (XELOX) is comparable to a current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin) in the first-line treatment of advanced (metastatic) colorectal cancer.

In the study, patients receiving XELOX lived for a median of 19.0 months, while patients receiving FOLFOX-4 lived for a median of 18.5 months. The consistency of these results were also further demonstrated in a subset population from the original two-arm part of the study (XELOX v. FOLFOX). These data will be presented later this week at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, Calif.

"These compelling data validate previous studies showing that XELOX is comparable to FOLFOX-4 for the treatment of advanced colorectal cancer, while providing the added flexibility of the proven oral component Xeloda," said Edward Chu, M.D., chief of medical oncology, Yale Cancer Center. "Together, these studies confirm the value and importance of combination therapy with oral Xeloda for the thousands of patients with this insidious disease."

Colorectal cancer is the third most common cancer in the United States. The American Cancer Society estimated that in 2008 more than 148,000 people in the U.S. would be diagnosed and about 50,000 people would die from the disease. (1)

Previous data reported from the NO16966 study showed that XELOX is comparable to FOLFOX-4 in terms of progression-free survival, and the addition of Avastin to chemotherapy (FOLFOX-4 and XELOX) significantly improved progression-free survival by investigator assessment compared to chemotherapy alone. Fu
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
2. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
3. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
4. DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
5. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
6. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
7. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
8. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
9. New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
10. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
11. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
(Date:8/29/2014)... -- , Industry professionals and media ... taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of #CPhIChat ... its kind global industry-wide Tweetchat for pharma professionals ... to stimulate conversations on key industry issues and ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
(Date:8/31/2014)... 1Heart Caregiver Services Director for Business Development ... Tee Barr conducted a brain fitness education lecture at ... Ayala and Social Services designee Lily are both appreciative ... fitness session. , Research studies have found that cognitive ... of dementia and memory loss. The six essential areas ...
(Date:8/31/2014)... Twin to twin transfusion syndrome (TTTS) ... before they were born, but an innovative fetal surgery at the ... chance at life. , Now, their parents David and Theresa Colp ... option available in St. Louis at the St. Louis Fetal Care ... Pub House (6655 Delmar Blvd, St Louis, MO 63130) on Friday, ...
(Date:8/31/2014)... 31, 2014 Ticket Down is ... at Dick’s Sporting Goods Park in suburban Denver. ... of games against other international teams on USA soil. ... brought a new soccer coach aboard, Miguel Herrera, and he ... build-up before the World Cup in Brazil, the Mexican team ...
(Date:8/31/2014)... UWDress.com, a renowned wedding dress manufacturer ... range of elegant formal bridesmaid dresses today. ... its high quality special occasion outfits. All its current ... 65% off). , Along with the greatly discounted ... The company’s promotional formal bridesmaid outfits are offered in ...
(Date:8/31/2014)... which finds that invisible blood in urine may be an ... guidelines for clinicians. , Scientists at the University of ... the age of 60 who had invisible blood in their ... have bladder cancer. The figure was around half those who ... indicator of bladder cancer. However, it was still higher than ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 2Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 3Health News:Elegant Formal Bridesmaid Dresses Today Unveiled By UWDress.com 2Health News:Invisible blood in urine may indicate bladder cancer 2
... -- The brains of people with autism concentrate more resources ... in areas used to plan and control thoughts and actions, ... people with autism have exceptional visual abilities, said the researchers ... 26 brain imaging studies that were conducted over 15 years ...
... Breast cancer risk can be assessed by examining ... preliminary study results presented at the AACR 102nd Annual ... method has the potential to provide a personalized assessment ... Arcaro, Ph.D., associate professor of veterinary and animal sciences ...
... Langone Medical Center have investigated a novel protein test ... accurately identify proteins secreted from cancerous tumors caused by ... Association for Cancer Research 102nd Annual Meeting 2011 on ... under the sponsorship of the National Cancer Institute,s Early ...
... , SUNDAY, April 3 (HealthDay News) -- New ... heart attack four years after the city was devastated ... Chronic stress, not being able to return home and ... situation, said the researchers, who updated their two-year post-Hurricane ...
... Health Study revealed that diabetes is associated with lower risk ... other cancers in both men and women. The data, to ... here April 2-6, also showed an association between diabetes and ... an association between diabetes and an increased risk for cancers ...
... SATURDAY, April 2 (HealthDay News) -- In a small preliminary ... number of episodes of a potentially dangerous irregular heartbeat known ... week also improved quality of life, lowering levels of the ... according to research to be presented Saturday at the annual ...
Cached Medicine News:Health News:Brains of People with Autism Focus More on Visual Skills 2Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:New test detects early-stage, asbestos-related pulmonary cancer 2Health News:Heart Attack Risk Plagues Post-Katrina New Orleans 2Health News:Avoiding or controlling diabetes may reduce cancer risk and mortality 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 3
... The Laserex Tango ophthalmic laser system provides ... SLT laser and a photodisruptor for posterior ... a frequency-doubled Nd:YAG producing pulsed 532 nm ... producing 1064 nm. The appropriate laser can ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Round handle....
5 mm concave jaws, cross action....
Medicine Products: